Marshall Wace »

Kyverna Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2024-06-30 $78k 10k 7.50
2024-03-31 $3.9M 156k 24.84

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Amazon.com Equity Option Put Option (AMZN)
Microsoft Corp Equity Option Put Option (MSFT)
Apple Common Stock (AAPL)
Spdr S&p 500 Etf Equity Option Call Option (SPY)
Nvidia Corp Equity Option Call Option (NVDA)
Alphabet Inc-a Common Stock (GOOGL)
Eli Lilly & Co Common Stock (LLY)
Alphabet Inc-c Common Stock (GOOG)
Adobe Common Stock (ADBE)
Meta Platforms-a Common Stock (META)
Johnson&johnson Common Stock (JNJ)
Humana Common Stock (HUM)
Boston Scientifc Common Stock (BSX)
Costco Wholesale Common Stock (COST)

View all positions for Marshall Wace

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Bain Capital Life Sciences Investors
Northpond Ventures
Jpmorgan Chase & Co
Deerfield Management Company
Rtw Investments
Novo A/S
BlackRock
Vanguard Group
Millennium Management
Insight Holdings
Franklin Resources
T. Rowe Price Associates
Wellington Management Company
Adage Capital Partners GP

View all funds holding Kyverna Therapeutics